News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
Osta Biotechnologies Inc. Appoints Dr. Alaoui-Jamali to its Scientific Advisory Board
March 6, 2007
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
MONTREAL, QUEBEC -- (MARKET WIRE) -- March 06, 2007 -- Osta Biotechnologies Inc. (TSX VENTURE: OBI) is pleased to announce the appointment of Dr. Moulay Alaoui-Jamali to its Scientific Advisory Board.
Twitter
LinkedIn
Facebook
Email
Print
People
MORE ON THIS TOPIC
Layoff Tracker
Merck Continues Cuts With 204 Laid Off in New Jersey
November 18, 2025
·
86 min read
·
BioSpace Editorial Staff
Mergers & acquisitions
J&J, Aiming for $50B in Cancer Sales, Buys Halda for $3B in Cash
November 17, 2025
·
2 min read
·
Dan Samorodnitsky
Collaboration
Lilly Bets More Than $2.6B for South Korea Biotech’s Bispecific Antibody Platform
November 17, 2025
·
2 min read
·
Tristan Manalac
Funding
Artios Pushes Cancer Pipeline Forward With $115M Series D
November 17, 2025
·
1 min read
·
Tristan Manalac
